Gross margin pressure from rising API costs
Geopolitical tensions may increase API prices, impacting gross margins. Management noted indirect impact but expects to manage within 80% gross margin band.
CORONAREMEDIES / bear-case history
Track the concerns that keep returning.
Corona Remedies · risk themes across the available quarters.
Research layer active
Bear-case history
Risks carried through the record.
medium
Integration and margin dilution from Wokadin acquisition
Wokadin acquisition may cause ~400bps gross margin correction in first year due to NLEM portfolio. Management expects 25% revenue growth but margin recovery uncertain.
Execution risk in new divisions and biosimilars
New infertility and multispecialty divisions, plus biosimilar launches, require ramp-up time. PCPM for new hires takes 3+ years to mature.